Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Integrative genetic analyses for drug repurposing identify emodin as a candidate modulator of STAT3 signaling in abdominal aortic aneurysm
Yingjie Liu; Zhijun Xu; Lin Deng; Chi Zhang; Xiao Ruan; Linlu Zhao; Ying Yang; Zanxin Wang; Haocheng LuShow moreShow less
Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China; Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China; Engineering Research Center of Tropical Medicine Innovation and Transformation, Ministry of Education, College of Pharmacy, Hainan Medical University, Haikou, 571199, China; Division of Cardiovascular Surgery, Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, 518000, ChinaShow moreShow less
Characterization of an adjustable partial portal vein ligation model reveals flow-dependent intimal and medial remodeling of the extrahepatic portal vein
Tamasi Roy; Kristóf Nagy; Péter Horváth; András Kriston; Ferenc Kovács; Sudha Ananth; Gergely Huszty; Zsuzsanna Kolostyák; Attila Fintha; Gábor CsányiShow moreShow less
Vascular Biology Center, Medical College of Georgia, Augusta University, 1460 Laney Walker Blvd., Augusta, GA 30912, USA; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; Synthetic and Systems Biology Unit, HUN-REN Biological Research Centre, Szeged, Hungary; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, 1460 Laney Walker Blvd., Augusta, GA, 30912, USAShow moreShow less
TUG-891-mediated FFAR4 activation attenuates vascular remodeling via suppression of aberrant browning and lipolysis in perivascular adipose tissue
Ai Jiang; Tianjiao Wang; Xiaobing Xu; Zhang Chen; Yujuan Li; Jiahe Du; Yixuan Jiang; Xinzhi LiShow moreShow less
School of Pharmacy, Faculty of Chinese Medicine & Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Taipa, Macao, China; State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, ChinaShow moreShow less
Aquaporin-1 facilitates the transport of hydrogen peroxide and nitric oxide during endothelium-dependent vasorelaxation
Omar Echeverría Rodríguez; Sebastián Ramírez Rodríguez; Sara Daniela Hernández Torres; Héctor Riveros Rosas; Itzell A. Gallardo Ortíz; Rafael Villalobos Molina; María Magdalena Vilchis LanderosShow moreShow less
Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México, Coyoacán, 04510 Mexico City, Mexico; Division of Research and Postgraduate Studies, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, 54090, State of Mexico, MexicoShow moreShow less
Pan-peroxisome proliferator-activated receptor agonist IVA337 alleviates secondary lymphedema via inhibiting TGFβ/SMAD2/3 signaling pathway
Jingjing Pang; Long Nguyen Hoang Do; Esteban Delgado; Jianan Zhao; Liam Flynn; Hongxia Liu; Michael Autieri; Xiaofeng Yang; Xiaolei LiuShow moreShow less
Lemole Center for Integrated Lymphatics and Vascular Research, United States of AmericaShow moreShow less
Multi-omics and experimental validation reveal the proliferative mechanism of ACSL4 in pulmonary hypertension and identify potential FDA-approved drugs via in silico screening
Wei Chen; Yiting Dong; Qihao Shi; Hongbing Meng; Jiawei Sun; Congmei Han; Chenjie Yan; Chendong Wu; Jing Wang; Adriana Georgescu; Keke Jin; Linbo YuanShow moreShow less
Wenzhou Medical University, Wenzhou, China; Renji College, Wenzhou Medical University, Wenzhou 325000, China; Xinjiang General Station of Exit and Entry Frontier Insp, Xinjiang, China; Department of Pathophysiology, School of Basic Medical Science, Wenzhou Medical University, Wenzhou, China; Department of Physiology, School of Basic Medical Science, Wenzhou Medical University, Wenzhou, China; Department of Pathophysiology and Cellular Pharmacology, Institute of Cellular Biology and Pathology ‘Nicolae Simionescu’ of Romanian Academy, Bucharest, RomaniaShow moreShow less
FAQ
How long does VASCULAR PHARMACOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 12 complete review records for VASCULAR PHARMACOLOGY. The fastest paper went from submission to acceptance in 5 days (Formoterol fumarate attenuates atherosclerosis and improves cardiometabolic dysfunction in ApoE-deficient mice, received 2026-08-09, accepted 2026-08-14); the slowest took 229 days. The average is 104.2 days and the median is 110.5 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
